MSD applies for injunction against companies infringing ezetimibe patent

Published: 2016-04-13 10:48:44

Updated: 2016-04-13 10:48:44

MSD applied for an injunction of sales prohibition against 3 companies, such as Daewoong Pharmaceutical, Handok and Alvogen Korea for infringement of the ezetimibe patent.

The 3 companies including Daewoong Pharmaceutical launched hyperlipidemia complexes combining ezetimibe and rosuvastatin on the 1^st even if the ezetimibe’s substance patent will be expired on the coming 29^th.

Thus, MSD star...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.